TruGraf Kidney
Commercial- Indications
- Kidney transplant rejection
Company intelligence / Profile preview
Transplant Genomics
Framingham, Massachusetts, United Statestransplantgenomics.com ↗
- Ownership
- Private
- Employees
- ~106
- Development stage
- Commercial
01
Overview
Transplant Genomics has developed and commercialized the TruGraf blood test, a non-invasive molecular diagnostic that detects "silent" sub-clinical acute rejection in stable kidney transplant recipients. The technology is supported by US patent 10,443,100 and has received CMS reimbursement approval as an alternative to surveillance biopsies. The company’s tests are offered through a CLIA-certified laboratory
- Therapeutic areas
- Nephrology
- Modalities
- Diagnostic test (gene expression profiling)Molecular diagnostic test
- Industry
- Molecular Diagnostics
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Collaborations with The Scripps Research Institute and Northwestern University for foundational IP/licensingViracor-Eurofins technology integration mentioned
Beyond the preview
Go deeper on Transplant Genomics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Transplant Genomics.